Use of a Claims-Based Algorithm to Characterize Uptake of Continuous Glucose Monitoring Among Older Adults With Type 1 and Type 2 Diabetes Meeting Medicare Coverage Criteria From 2017 to 2019
Year: 2025
Type: article
Source: Diabetes Care
DOI: 10.2337/dc25-1593
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Boehringer Ingelheim, Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Bayer, GlaxoSmithKline, Sanofi, AbbVie, Regeneron Pharmaceuticals, Insulet Corporation, Sarepta Therapeutics, Dexcom, Bayer HealthCare, Novo Nordisk, Astellas Pharma, Intas Pharmaceuticals, National Institutes of Health, University of North Carolina at Chapel Hill, UCB US, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G3069299928, The role of type 2 diabetes on skeletal muscle atrophy and recovery following bed rest in older adults, G7657979593, Diabetes RElated to Acute Pancreatitis and its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics (DREAM-ON), G9000138291, Propensity scores and preventive drug use in the elderly, Building a Real-World Evidence Base for Continuous Glucose Monitoring in Older Adults with Diabetes, Data Coordinating Center for the Type 1 Diabetes in Acute Pancreatitis Consortium, Continuation of Type 1 Diabetes in Acute Pancreatitis Consortium – UF Health and AdventHealth Combined Clinical Center, North Carolina Diabetes Research Center
OpenAlex ID: W4413964935